AMLX
Amylyx Pharmaceuticals, Inc.
Amylyx Pharmaceuticals, Inc. (AMLX) has 13 SEC Form 4 filings (14 transaction rows) in the rolling window, disclosed by 6 distinct insiders. Most recent filing: Jul 13, 2026.
The most active filer is Chief Legal Officer Mazzariello Gina with 4 filings. Insiders have net sold $1.7M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Joshua Cohen
- Employees:136
- HQ:Cambridge, MA, US
- IPO:2022-01-07
Insider Buying
$51K
reported purchases (SEC code P)
Insider Selling
$1.7M
reported sales (SEC code S)
Unique Insiders
6
in the rolling window
Market Cap
$2.5B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Mazzariello GinaFirst in 4 months | Chief Legal Officer | Sale | 15,000 | $275K | Jul 13 | SEC ↗ |
Mazzariello GinaFirst in 4 months | Chief Legal Officer | Sale | 15,000 | $264K | Jul 13 | SEC ↗ |
Firestone KarenFirst filing | Director | Purchase | 3,800 | $51K | May 26 | SEC ↗ |
Cohen Joshua BFirst filing | Co-Chief Executive Officer | Sale | 29,282 | $424K | Mar 4 | SEC ↗ |
| Chief Legal Officer | Sale | 6,844 | $99K | Mar 4 | SEC ↗ | |
Bedrosian Camille LFirst filing | Chief Medical Officer | Sale | 6,461 | $94K | Mar 4 | SEC ↗ |
Klee Justin B.First filing | Co-Chief Executive Officer | Sale | 29,282 | $424K | Mar 4 | SEC ↗ |
FRATES JAMES MFirst filing | Chief Financial Officer | Sale | 7,909 | $115K | Mar 4 | SEC ↗ |
Mazzariello GinaFirst filing | Chief Legal Officer | Sale | 3,419 | $48K | Feb 25 | SEC ↗ |
Related companies
Amylyx Pharmaceuticals, Inc. is in the Healthcare sector.